1. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
- Author
-
Cutuli, Salvatore Lucio, Artigas, Antonio, Fumagalli, Roberto, Monti, Gianpaola, Ranieri, Vito Marco, Ronco, Claudio, Antonelli, Massimo, The EUPHAS 2 Collaborative Group, Null, Maviglia, Riccardo, Cicconi, Sandra, Silvestri, Davide, Bello, Giuseppe, Brendolan, Alessandra, Nalesso, Federico, Villa, Gianluca, Piccinni, Pasquale, Martin, Erica, Cantaluppi, Vincenzo, Vesconi, Sergio, Casella, Giampaolo, Fasanella, Egidio, Debitonto, Michele, Monza, Gianmario, Blasetti, Angelo, Coletta, Rosaria, D’Ambrosio, Michele, Cinnella, Gilda, Murino, Patrizia, Piscitelli, Eugenio, Centonze, Gaetano, Cucurachi, Marco, Altieri, Giuseppe, Leonardo, Vincenzo, Idra, Anna Sara, Del Rosso, Goffredo, Polidoro, Maria, Stigliano, Nicola, Pittella, Giuseppe, Paternoster, Gianluca, Pulito, Giuseppe, Puscio, Daniela, Cingolani, Diego, Falzetti, Gabriele, Vecchiarelli, Pietro, Giunta, Francesco, Forfori, Francesco, Castiglione, Giacomo, Greco, Stefano, Capra, Carlo, Crema, Luciano, Tamayo, Leonor, Urbano, Cristina, Pezza, Brunello, Zarrillo, Nadia, Di Monaco, Pasquale, Climaco, Giuseppe, De Negri, Pasquale, Modano, Pasqualina, Pagliarulo, Riccardo, Petrillo, Claudio, Stripoli, Tania, Oggioni, Roberto, Campiglia, Laura, Valletta, Anna Rita, Lugano, Manuela, Milella, Domenico, Micucci, Laura, Reist, Ursula, Ensner, Rolf, Gianbarba, Christian, Brander, Lukas, Paul, Rajib, Crawla, Rajesh, Jasujia, Sanjeev, Pande, Rajesh, Dileep, Pratibha, Sundar, Sankaran, Ganesan, Raju, Dewan, Sandeep, Nangia, Vivek, Mani, Raj Kumar, Singh, Omender, Sathe, Pracee, Sachin, Gupta, D’Costa, Pradeep M., Srivanas, Samavedam, Singh, Yogendra Pal, Doi, Kent, Taki, Fumika, Roca, Ricard Ferrer, Medina, Eduardo Romay, Gernacho, Josè, Martí, Francisco, Martinez Ruiz, Alberto, Martinez Sagasti, Fernando, Crespo, Rafael Zaragoza, Torti, Paola, Terzi, Valeria, Cutuli, S.L., Artigas, A., Fumagalli, R., Monti, G., Ranieri, V.M., Ronco, C., Antonelli, M., The EUPHAS 2 Collaborative Group and Maviglia, R., Cicconi, S., Silvestri, D., Bello, G., Brendolan, A., Nalesso, F., Villa, G., Piccinni, P., Martin, E., Cantaluppi, V., Vesconi, S., Casella, G., Fasanella, E., Debitonto, M., Monza, G., Blasetti, A., Coletta, R., D’Ambrosio, M., Cinnella, G., Murino, P., Piscitelli, E., Centonze, G., Cucurachi, M., Altieri, G., Leonardo, V., Idra, A.S., Del Rosso, G., Polidoro, M., Stigliano, N., Pittella, G., Paternoster, G., Pulito, G., Puscio, D., Cingolani, D., Falzetti, G., Vecchiarelli, P., Giunta, F., Forfori, F., Castiglione, G., Greco, S., Capra, C., Crema, L., Tamayo, L., Urbano, C., Pezza, B., Zarrillo, N., Di Monaco, P., Climaco, G., De Negri, P., Modano, P., Pagliarulo, R., Petrillo, C., Stripoli, T., Oggioni, R., Campiglia, L., Valletta, A.R., Lugano, M., Milella, D., Micucci, L., Reist, U., Ensner, R., Gianbarba, C., Brander, L., Paul, R., Crawla, R., Jasujia, S., Pande, R., Dileep, P., Sundar, S., Ganesan, R., Dewan, S., Nangia, V., Mani, R.K., Singh, O., Sathe, P., Sachin, G., D’Costa, P.M., Srivanas, S., Singh, Y.P., Doi, K., Taki, F., Roca, R.F., Medina, E.R., Gernacho, J., Martí, F., Martinez-Ruiz, A., Martinez-Sagasti, F., Crespo, R.Z., Torti, P., Terzi, V., Cutuli, S, Artigas, A, Fumagalli, R, Monti, G, Ranieri, V, Ronco, C, and Antonelli, M
- Subjects
hypotension ,retrospective study ,030232 urology & nephrology ,race difference ,polymyxin B, abdominal infection ,tachycardia ,Critical Care and Intensive Care Medicine ,0302 clinical medicine ,respiratory function ,Septic shock ,antibiotic therapy ,EAA ,Medicine ,Respiratory function ,randomized controlled trial (topic) ,Gram negative sepsi ,kidney function ,Extracorporeal endotoxin removal ,intensive care ,lung infection ,endotoxemia ,adult ,continuous infusion ,clinical practice ,aged ,female ,priority journal ,liver function ,multicenter study (topic) ,disease severity ,SOFA score ,Infection ,survival rate ,medicine.medical_specialty ,Polymyxin-B hemoperfusion ,Sepsis ,Sepsi ,cardiovascular response ,European ,blood clotting ,Article ,03 medical and health sciences ,length of stay ,male ,blood clotting disorder ,Intensive care ,Internal medicine ,Settore MED/41 - ANESTESIOLOGIA ,Sequential Organ Failure Assessment Score ,human ,MED/41 - ANESTESIOLOGIA ,survival time ,Survival rate ,hospital mortality ,Asian ,business.industry ,Research ,Abdominal Infection ,030208 emergency & critical care medicine ,bleeding ,medicine.disease ,major clinical study ,Surgery ,hospital admission ,multicenter study ,treatment outcome ,Liver function ,business - Abstract
Background: In 2010, the EUPHAS 2 collaborative group created a registry with the purpose of recording data from critically ill patients suffering from severe sepsis and septic shock treated with polymyxin-B hemoperfusion (PMX-HP) for endotoxin removal. The aim of the registry was to verify the application of PMX-HP in the daily clinical practice. Methods: The EUPHAS 2 registry involved 57 centers between January 2010 and December 2014, collecting retrospective data of 357 patients (297 in Europe and 60 in Asia) suffering from severe sepsis and septic shock caused by proved or suspected infection related to Gram negative bacteria. All patients received atleast one cycle of extracorporeal endotoxin removal by PMX-HP. Results: Septic shock was diagnosed in 305 (85.4%) patients. The most common source of infection was abdominal (44.0%) followed by pulmonary (17.6%). Gram negative bacteria represented 60.6% of the pathogens responsible of infection. After 72h from the first cycle of PMX-HP, some of the SOFA score components significantly improved with respect to baseline: cardiovascular (2.16±1.77 from 3.32±1.29, p 
- Published
- 2016